U.S. Markets closed
  • S&P 500

    3,345.51
    -6.09 (-0.18%)
     
  • Dow 30

    27,534.44
    -49.62 (-0.18%)
     
  • Nasdaq

    11,120.16
    +2.64 (+0.02%)
     
  • Russell 2000

    1,507.77
    -2.57 (-0.17%)
     
  • Crude Oil

    39.12
    -1.48 (-3.65%)
     
  • Gold

    1,901.90
    +19.60 (+1.04%)
     
  • Silver

    24.44
    +0.84 (+3.56%)
     
  • EUR/USD

    1.1741
    +0.0073 (+0.6223%)
     
  • 10-Yr Bond

    0.6460
    -0.0170 (-2.56%)
     
  • Vix

    26.20
    +0.01 (+0.04%)
     
  • GBP/USD

    1.2864
    +0.0023 (+0.1762%)
     
  • USD/JPY

    105.6770
    +0.1580 (+0.1497%)
     
  • BTC-USD

    10,740.60
    -103.61 (-0.96%)
     
  • CMC Crypto 200

    230.20
    +0.53 (+0.23%)
     
  • FTSE 100

    5,897.50
    -30.43 (-0.51%)
     
  • Nikkei 225

    23,539.10
    +27.48 (+0.12%)
     

Varian Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Varian Medical Systems, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Varian Medical Systems, Inc. (NYSE: VAR) to Siemens Healthineers AG for $177.50 per share is fair to Varian shareholders. On behalf of Varian shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

(PRNewsfoto/Halper Sadeh LLP)
(PRNewsfoto/Halper Sadeh LLP)

If you are a Varian shareholder and would like to discuss your legal rights and options, please visit Varian Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Varian and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible consideration for Varian shareholders; (2) determine whether Siemens is underpaying for Varian; and (3) disclose all material information necessary for Varian shareholders to adequately assess and value the proposed transaction.

If you are a Varian shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/varian-medical-systems-inc-var-stock-merger-siemens or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com 
zhalper@halpersadeh.com  
https://www.halpersadeh.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/varian-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-varian-medical-systems-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-301104798.html

SOURCE Halper Sadeh LLP